Ovelle Bio Corp.
PrivateLast Round
Seed Round
Jun 2, 2026
Total Funding Raised
$667,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Ovelle Bio Corp. operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Grant round in September 2025.
Ovelle Bio Corp. is a biotechnology company developing in vitro gametogenesis (IVG), a revolutionary approach to create eggs from somatic cells to provide a more effective and less invasive alternative to traditional IVF.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine
Business Model
B2B2C
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ovelle Bio Corp. Comparables
Compare Ovelle Bio Corp. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ivy Natal | 92% | |
| Vitra Labs | 88% | |
| Dioseve Inc. | 85% |
For institutional investors. Book with your work email.
Ovelle Bio Corp. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jun 2, 2026 | ||||
| Grant | Sep 1, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ovelle Bio Corp. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Survival and Flourishing Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 6, 86% of headcount.
- Jun 2, 2026
$7M round raised.
For institutional investors. Book with your work email.
Ovelle Bio Corp. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ovelle Bio Corp.'s valuation, stock price, and market status.
Is Ovelle Bio Corp. a public or private company?
Ovelle Bio Corp. is a private company.
What is the current stock price of Ovelle Bio Corp.?
Ovelle Bio Corp. is a private company, so its shares have no public market price. Caplight tracks Ovelle Bio Corp.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ovelle Bio Corp. worth (valuation)?
Valuation information for Ovelle Bio Corp. is not publicly available.
Can I buy Ovelle Bio Corp. stock?
Ovelle Bio Corp. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ovelle Bio Corp.'s last funding round?
Ovelle Bio Corp.'s most recent funding round was Seed Round on June 2, 2026.
Who are the main investors in Ovelle Bio Corp.?
Key investors in Ovelle Bio Corp. include Survival and Flourishing Fund.
Will Ovelle Bio Corp. IPO soon?
No public IPO plans have been announced for Ovelle Bio Corp..
How can I track Ovelle Bio Corp. secondary market activity?
Caplight tracks bids, offers, and trades in Ovelle Bio Corp.'s shares on secondary markets.